MedTrace Logo

CNKSR2 Natural History Study

NCT06500260 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2024-07-15

No results posted yet for this study

Summary

This prospective natural history study is being conducted to define the electroclinical, neurodevelopmental, and behavioral characteristics of CNKSR2 epilepsy aphasia syndrome (EAS) and intellectual disability (ID) in children aged 6 to 21 years old with CNKSR2 mutations.

The data collected from this study will serve as an external control to eventual clinical trials examining precision medicine investigational therapeutics that aim to improve the seizure burden and neurodevelopmental outcomes in patients with CNKSR2 EAS/ID.

Conditions

  • Developmental Dysphasia
  • Epileptic Encephalopathy, Childhood-Onset
  • X-Linked Intellectual Disability

Sponsors & Collaborators

Principal Investigators

Eligibility

Min Age
6 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06500260 on ClinicalTrials.gov